You are here

Science

Clinical Trials of Coronavirus Drugs Are Taking Longer Than Expected

 

As the coronavirus pandemic continues to wreak havoc in the United States and treatments are needed more than ever, clinical trials for some of the most promising experimental drugs are taking longer than expected.

Researchers at a dozen clinical trial sites said that testing delays, staffing shortages, space constraints and reluctant patients were complicating their efforts to test monoclonal antibodies, man-made drugs that mimic the molecular soldiers made by the human immune system.

Problem, Solution, SitRep, or ?: 

Study hints, can’t prove, survivor plasma fights COVID-19

Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they’ll ever get a clear answer.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Africa begins continent-wide study of COVID-19 antibodies

JOHANNESBURG (AP) — An Africa-wide study of antibodies to the coronavirus has begun, while evidence from a smaller study indicates that many more people have been infected than official numbers show, the Africa Centers for Disease Control and Prevention said Thursday.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Science
howdy folks